Commonwealth Equity Services, LLC Novartis Ag Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Novartis Ag stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 203,510 shares of NVS stock, worth $19.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

203,510

Previous 216,679 6.08%

Holding current value

$19.8 Million

Previous $23.1 Million 1.47%

% of portfolio

0.04%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$106.13 - $120.89 $1.4 Million - $1.59 Million	-13,169 Reduced 6.08%	203,510 $23.4 Million
Q2 2024 Jul 31, 2024	SELL	$92.57 - $107.37 $655,025 - $759,750	-7,076 Reduced 3.16%	216,679 $23.1 Million
Q1 2024 Apr 29, 2024	SELL	$95.27 - $108.47 $517,411 - $589,100	-5,431 Reduced 2.37%	223,755 $21.6 Million
Q4 2023 Feb 06, 2024	BUY	$92.27 - $101.54 $4,798 - $5,280	52 Added 0.02%	229,186 $23.1 Million
Q3 2023 Oct 23, 2023	SELL	$94.73 - $105.13 $1.56 Million - $1.73 Million	-16,423 Reduced 6.69%	229,134 $23.3 Million
Q2 2023 Aug 10, 2023	BUY	$92.52 - $104.91 $732,203 - $830,257	7,914 Added 3.33%	245,557 $24.8 Million
Q1 2023 May 11, 2023	BUY	$80.03 - $92.81 $1.44 Million - $1.67 Million	18,021 Added 8.21%	237,643 $21.9 Million
Q4 2022 Feb 07, 2023	BUY	$75.55 - $92.52 $717,876 - $879,125	9,502 Added 4.52%	219,622 $19.9 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $499,737 - $584,467	-6,698 Reduced 3.09%	210,120 $16 Million
Q2 2022 Jul 19, 2022	SELL	$80.52 - $93.75 $62,644 - $72,937	-778 Reduced 0.36%	216,818 $18.3 Million
Q1 2022 May 04, 2022	BUY	$80.11 - $90.62 $5,848 - $6,615	73 Added 0.03%	217,596 $19.1 Million
Q4 2021 Jan 31, 2022	SELL	$79.7 - $88.13 $1.82 Million - $2.01 Million	-22,792 Reduced 9.48%	217,523 $27.8 Million
Q3 2021 Oct 29, 2021	SELL	$81.78 - $95.14 $977,025 - $1.14 Million	-11,947 Reduced 4.74%	240,315 $19.7 Million
Q2 2021 Aug 11, 2021	BUY	$85.24 - $94.15 $181,220 - $200,162	2,126 Added 0.85%	252,262 $23 Million
Q1 2021 May 04, 2021	SELL	$83.5 - $98.47 $466,013 - $549,561	-5,581 Reduced 2.18%	250,136 $21.4 Million
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $3.91 Million - $4.73 Million	-50,112 Reduced 16.39%	255,717 $24.1 Million
Q3 2020 Nov 05, 2020	SELL	$82.14 - $91.0 $2.17 Million - $2.4 Million	-26,421 Reduced 7.95%	305,829 $26.6 Million
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $1.98 Million - $2.23 Million	24,449 Added 7.94%	332,250 $29 Million
Q1 2020 May 11, 2020	BUY	$70.67 - $99.01 $1.08 Million - $1.52 Million	15,305 Added 5.23%	307,801 $25.4 Million
Q4 2019 Feb 05, 2020	BUY	$84.35 - $95.37 $1.23 Million - $1.4 Million	14,638 Added 5.27%	292,496 $27.7 Million
Q3 2019 Oct 30, 2019	BUY	$85.54 - $94.26 $184,082 - $202,847	2,152 Added 0.78%	277,858 $24.1 Million
Q2 2019 Jul 19, 2019	BUY	$75.4 - $92.8 $259,677 - $319,603	3,444 Added 1.26%	275,706 $25.2 Million
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $89,178 - $102,001	-1,184 Reduced 0.43%	272,262 $26.2 Million
Q4 2018 Feb 11, 2019	BUY	$73.66 - $82.02 $370,509 - $412,560	5,030 Added 1.87%	273,446 $23.5 Million
Q3 2018 Nov 06, 2018	BUY	$66.94 - $77.43 $11,513 - $13,317	172 Added 0.06%	268,416 $23.1 Million
Q2 2018 Jul 31, 2018	BUY	$64.91 - $73.36 $1.03 Million - $1.16 Million	15,792 Added 6.26%	268,244 $20.3 Million
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $277,758 - $332,055	3,946 Added 1.59%	252,452 $20.4 Million
Q4 2017 Feb 12, 2018	BUY	$72.33 - $77.64 $18 Million - $19.3 Million	248,506	248,506 $20.9 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Novartis Ag Transaction History